» Articles » PMID: 14528055

Role for the Ubiquitin-proteasome System in Parkinson's Disease and Other Neurodegenerative Brain Amyloidoses

Overview
Specialty Biochemistry
Date 2003 Oct 7
PMID 14528055
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Many neurodegenerative brain amyloidoses, including Alzheimer's and Parkinson's disease, are characterized by selective neuronal loss together with the appearance of intraneuronal ubiquitin-positive proteinaceous aggregates or inclusion bodies. These features usually result from the abnormal accumulation and processing of mutant, misfolded, or damaged intracellular proteins. It has recently become clear that both genetic factors and aberrant proteolytic degradation may therefore play a major role in neuronal degeneration. Indeed, the linkage of two genes directly involved in the ubiquitin-proteasome system (UPS) in familial Parkinson's disease clearly indicates a central role for the UPS in neurodegeneration, and thus Parkinson's disease is considered the prototypical disorder associated with UPS dysfunction. In this review, we provide an overview of the key genes/proteins implicated in the abnormal UPS-mediated proteolytic processing of unwanted proteins observed in neurodegenerative brain amyloidoses. We also provide an outline of the various components and pathways involved in the normal cellular functioning of the UPS and discuss the mechanisms by which UPS dysfunction can compromise neuronal integrity. A more complete understanding of the UPS and its relationship to the neurodegenerative process will undoubtedly provide tremendous insight into the molecular pathogenesis of amyloidogenic neurodegenerative disorders and will allow the development of novel rational therapies for treating these disorders.

Citing Articles

Advances in Proteasome Enhancement by Small Molecules.

George D, Tepe J Biomolecules. 2021; 11(12).

PMID: 34944433 PMC: 8699248. DOI: 10.3390/biom11121789.


Lipidomic Alterations in the Mitochondria of Aged Parkin Null Mice Relevant to Autophagy.

Gaudioso A, Garcia-Rozas P, Casarejos M, Pastor O, Rodriguez-Navarro J Front Neurosci. 2019; 13:329.

PMID: 31068772 PMC: 6491511. DOI: 10.3389/fnins.2019.00329.


Cognitive Deficits and Associated ERP N400 Abnormalities in FXTAS With Parkinsonism.

Wang X, Yang J, Soohoo R, Cotter D, Yuan M, Xia J Front Genet. 2018; 9:327.

PMID: 30279697 PMC: 6153313. DOI: 10.3389/fgene.2018.00327.


Mechanisms of selective autophagy and mitophagy: Implications for neurodegenerative diseases.

Chu C Neurobiol Dis. 2018; 122:23-34.

PMID: 30030024 PMC: 6396690. DOI: 10.1016/j.nbd.2018.07.015.


Alpha-synuclein aggregation, Ubiquitin proteasome system impairment, and L-Dopa response in zinc-induced Parkinsonism: resemblance to sporadic Parkinson's disease.

Kumar V, Singh D, Singh B, Singh S, Mittra N, Jha R Mol Cell Biochem. 2017; 444(1-2):149-160.

PMID: 29198021 DOI: 10.1007/s11010-017-3239-y.


References
1.
Lee M, Stirling W, Xu Y, Xu X, Qui D, Mandir A . Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc Natl Acad Sci U S A. 2002; 99(13):8968-73. PMC: 124407. DOI: 10.1073/pnas.132197599. View

2.
Zhang , Hattori , LEROY , Morris , Kubo , Kobayashi . Association between a polymorphism of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) gene and sporadic Parkinson's disease. Parkinsonism Relat Disord. 2000; 6(4):195-197. DOI: 10.1016/s1353-8020(00)00015-8. View

3.
Zhang Y, Gao J, Chung K, Huang H, Dawson V, Dawson T . Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci U S A. 2000; 97(24):13354-9. PMC: 27228. DOI: 10.1073/pnas.240347797. View

4.
Goedert M . Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci. 2001; 2(7):492-501. DOI: 10.1038/35081564. View

5.
Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E . The ubiquitin pathway in Parkinson's disease. Nature. 1998; 395(6701):451-2. DOI: 10.1038/26652. View